The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.
The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis
Open accessAbstract
There is interest in the role of peripheral interleukin-6 (IL-6) in depression and the effect of treatment (e. g., pharmacologic, psychosocial, neurostimulation). However, the relationship between cognitive behavioral therapy (CBT), IL-6 and depression has not yet been established. We conducted a meta-analysis to explore the association between CBT and change of peripheral IL-6 levels in depressive symptoms or major depressive disorder (MDD). A systematic search of online databases (i.e., PubMed, Web of Science, Google Scholar, PsycINFO, and Cochrane Library) was completed from inception to May 2021. In total, 10 eligible papers with 940 participants reporting peripheral IL-6 levels before and after CBT were included in the analysis. The main result indicates that peripheral levels of IL-6 were significantly lower after CBT intervention in individuals with depression, with a small effect (SMD = 0.38, 95% CI: 0.07, 0.69, p = 0.02). The results of subgroup analyses demonstrate that (1) there was a significant decrease in IL-6 for studies that were equal to or <8 weeks in duration vs. more than 8 weeks in duration, and (2) IL-6 was significantly reduced in the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis (i.e., DSM-IV, DSM-IV-TR, or DSM-V) of MDD, but not for the subgroup without DSM diagnosis. Publication year was identified as a potential contributor to heterogeneity of the results from our analysis. Taken together, our findings support the notion that CBT influences peripheral IL-6 in individuals with depression and represents a point of commonality with other antidepressant treatment modalities (e.g., antidepressants). Systematic Review Registration: https://doi.org/10.17605/osf.io/tr9yh, identifier: 10.17605/osf.io/tr9yh.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that peripheral IL-6 levels were significantly lower after CBT in individuals with depression, with a small pooled effect. Subgroup analyses suggested the effect was significant for CBT duration ≤8 weeks and for DSM-diagnosed MDD, while publication year contributed to heterogeneity.
Key findings
- Across 10 studies and 940 participants, peripheral IL-6 was significantly lower after CBT intervention, with a small effect (SMD = 0.38, 95% CI: 0.07, 0.69, p = 0.02); heterogeneity was high (p < 0.00001; I² = 79%).
- Subgroup analysis by treatment duration found a significant decrease in IL-6 for studies ≤8 weeks (SMD = 0.86, 95% CI: 0.49, 1.23, p < 0.00001), but no significant difference for studies >8 weeks (p > 0.05).
- Subgroup analysis by diagnosis found a significant decrease in the DSM diagnosis subgroup (SMD = 0.41, 95% CI: 0.01, 0.80, p = 0.05), but not in the subgroup without DSM diagnosis (p > 0.05).
- Meta-regression identified publication year as a statistically significant contributor to heterogeneity (β = −0.49, 95% CI = −0.88, −0.09, t = −2.86, p = 0.02; adjusted R² = 52.91%); no publication bias was detected by Egger’s test (p = 0.208) or Begg’s test (p = 0.180).
Methods
- Systematic search of PubMed, Web of Science, Google Scholar, PsycINFO, and Cochrane Library from inception to May 2021, plus reference-list searching, for studies reporting peripheral IL-6 before and after CBT in adults with depression.
- Included 10 eligible papers with 940 participants; inclusion required adults ≥18 years with DSM-defined MDD or a verified scale for depressive symptoms, pre/post CBT IL-6 levels, and RCT, open-label, or longitudinal pre-test–post-test designs.
- Pooled analysis used Review Manager 5.4.1 and Stata 12.0; because of high heterogeneity, a random-effects model was used, with SMD and 95% CI, plus subgroup analyses, meta-regression, sensitivity analysis, Egger’s/Begg’s tests, and GRADE quality assessment.
Limitations
- The paper states that the sample size was relatively small (only 10 eligible studies), that included studies had varying definitions of depression and five included subthreshold depression, that sensitivity analysis indicated insufficient stability, that limited information prevented thorough analysis of heterogeneity sources, that residual confounding could not be controlled, and that prior antidepressant treatment may affect IL-6 but medication status could not be distinguished.
- Evident from the text: heterogeneity was high in the main analysis (I² = 79%), one study did not report treatment duration, one did not include sex, and one did not mention the IL-6 measure method.
- Evident from the text: the review pools heterogeneous designs and populations, including RCTs and pre-post studies, and cannot determine whether the CBT–IL-6 relationship is causal, predictive, or moderational.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 16 Not checked · 39 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 10 eligible papers with 940 participants reporting peripheral IL-6 levels before and after CBT were included in the analysis.”
- Also stated in: § Search Results · plain
“Finally, 10 studies were eligible for inclusion in our meta-analysis (23, 27–35).”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Abstract
plainn = 940- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Search Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“IL-6 was significantly reduced in the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis (i.e., DSM-IV, DSM-IV-TR, or DSM-V) of MDD, but not for the subgroup without DSM diagnosis.”
- Also stated in: § Subgroup Analysis · plain
“there was significant difference in the subgroup DSM diagnosis (SMD = 0.41, 95%CI: 0.01, 0.80, p = 0.05), whereas there was no significant difference in subgroup without DSM diagnosis (p > 0.05).”
- Also stated in: § Discussion · plain
“The association between CBT and change in peripheral IL-6 was delimited to those studies that codified the diagnosis of MDD using the DSM (i.e., DSM-IV, DSM-IV-TR, or DSM-V).”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Subgroup Analysis · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the subgroup of developed countries, IL-6 levels do not have a significant overall comprehensive effect (p = 0.11), and its heterogeneity is also large (p < 0.0001, I2 = 82%), indicating that subgroup analysis of the classification of developed and developing countries cannot explain the heterogeneity sources of IL-6 levels in all included studies.”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Results > Subgroup Analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“IL-6 was significantly reduced in the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis (i.e., DSM-IV, DSM-IV-TR, or DSM-V) of MDD, but not for the subgroup without DSM diagnosis.”
- Also stated in: § Subgroup Analysis · plain
“there was significant difference in the subgroup DSM diagnosis (SMD = 0.41, 95%CI: 0.01, 0.80, p = 0.05), whereas there was no significant difference in subgroup without DSM diagnosis (p > 0.05).”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Subgroup Analysis · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among them, the analysis results of the year of paper publication were statistically significant [β = −0.49, 95% CI = (−0.88, −0.09), t = −2.86, p = 0.02], and the goodness-of-fit of the model was good (Tau2 = 1.423).”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Results > Meta-Regression Analysis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
24 more claims
Create a free account to see all 55 claims and to verify the 26 references still open.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 19
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = 1.34reported p = .18 · recomputed p = .180
“z = 1.34, p = .180”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Methods > Eligibility Criteria
“Or had a verified scale to assess depressive symptoms (including subthreshold depression: clinically relevant depressive symptoms, without meeting criteria for a full-blown MDD)”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Methods > Eligibility Criteria
“studies including subjects that did not have a DSM-defined diagnosis of MDD, and/or included case groups with comorbid mental disorder diagnoses (e.g., schizophrenia, bipolar disorder) without depressive symptoms”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Results > Subgroup Analysis
“There was low heterogeneity and significant difference among subgroups (p = 0.83, I2 = 0%).”
§ The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis > Methods > Statistical Analysis
“A two-tailed P <0.05 were considered significant in all test.”
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Stephan, A. H., Barres, B. A., & Stevens, B. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113810 · Cited by 1,113
Deverman, B. E., & Patterson, P. H. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.002 · Cited by 865
An, H., He, R.-H., Zheng, Y.-R., & Tao, R. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5562-1_16 · Cited by 833
Cited by
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 92
Ortega, M. A., Fraile‐Μartinez, O., Montero, C. G., Díaz, R., López-González, L., Monserrat, J., Barrena-Blázquez, S., Álvarez-Mon, M. Á., Lahera, G., & Álvarez‐Mon, M. (2024) · Military Medical Research · doi:10.1186/s40779-024-00577-w · Cited by 39
Kim, K. Y., Shin, K. Y., & Chang, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813907 · Cited by 25
Biomarker opportunities in the treatment of cancer-related depression
Panjwani, A. A., Aguiar, S., Gascon, B., Brooks, D. G., & Li, M. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.10.003 · Cited by 23
Klyne, D. M., Hall, M., Smith, S. S., Barbe, M. F., Egorova, N., Serafimovska, A., Hodges, P. W., & Suraev, A. S. (2026) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2026.103509 · Cited by 11
Metadata
- Authors
- Ma, H., Xu, J., Li, R., McIntyre, R. S., Teopiz, K. M., Cao, B., & Yang, F.
- Affiliations
- Southwest University (CN)
- University of Toronto (CA)
- Corresponding author
- Cao, Bing
- Yang, Fahui
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2022-05-13
- Volume
- 13
- Pages
- 844176-844176
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC9136073
- OpenAlex
- W4280551526
- Cited by
- 22
- References
- 53
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 5 · 2023: 2 · 2022: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministry of Education, India
- Southwest University (SWU019039)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- cognitive behavioral therapy, interleukin-6, depression, major depressive disorder, psychosocial interventions, antidepressant effects, treatment duration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.